SuperworthAmylyx Pharmaceuticals shares outstanding AMLX
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 111.2M
- On a year earlier
- +24.7%
- more shares
Amylyx Pharmaceuticals had 111.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 24.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 109.8M | +60% |
| FY2024 | 68.6M | −1% |
| FY2023 | 69.5M | +6% |
| FY2022 | 65.4M | +847% |
| FY2021 | 6.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 111.2M | +25% | |
| Q1 FY26 | 110.6M | +29% | |
| Q4 FY25 | 109.8M | +60% | |
| Q3 FY25 | 93.3M | +37% | |
| Q2 FY25 | 89.1M | +31% | |
| Q1 FY25 | 85.7M | +26% | |
| Q4 FY24 | 68.6M | −1% | |
| Q3 FY24 | 68.1M | −2% | |
| Q2 FY24 | 68M | −3% | |
| Q1 FY24 | 67.9M | −4% | |
| Q4 FY23 | 69.5M | +6% | |
| Q3 FY23 | 69.7M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Amylyx Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.